Interleukin-2-unresponsive immune defects in good syndrome: Letter to the Editor

Clin Immunol. 2010 Jun;135(3):496-8. doi: 10.1016/j.clim.2010.01.016. Epub 2010 Feb 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cell Differentiation / drug effects
  • Cell Differentiation / immunology
  • Cytomegalovirus Infections / etiology
  • Encephalitis, Viral / etiology
  • Fatal Outcome
  • Female
  • Humans
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / drug therapy*
  • Immunologic Deficiency Syndromes / immunology*
  • Immunologic Factors / therapeutic use*
  • Immunologic Memory
  • Interleukin-2 / therapeutic use*
  • Middle Aged
  • T-Lymphocyte Subsets / cytology
  • T-Lymphocyte Subsets / drug effects
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocytes / cytology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Thymoma / complications
  • Thymoma / drug therapy
  • Thymoma / immunology

Substances

  • Antiviral Agents
  • Immunologic Factors
  • Interleukin-2